Company Update (NYSE:STJ): St. Jude Medical (STJ) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of St. Jude Medical, Inc.; Are Shareholders Getting a Fair Price?

[PR Newswire] – SAN DIEGO, April 28, 2016 /PRNewswire/ — Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of St. Jude Medical, Inc. (NYSE: STJ) breached their … Read more on this. St. Jude Medical Inc. (STJ) , with a current market cap of $21.87B, ended trading yesterday at $61.95. Looking at today’s market, STJ one day range is $77.09 to $77.09 with a one year range of $48.83 to $80.84. St. Jude Medical (STJ) shares are currently priced at 15.26x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 4.37x earnings multiple for the same period. And for dividend hunters, the company pays shareholders $1.24 per share annually in dividends, yielding 2.04%. In a review of the consensus earnings estimate this quarter, 22 sell-side analysts are looking at $1.06 per share, which would be $0.03 better than the year-ago quarter and a $0.04 sequential increase. What we find to be interesting is that the full-year EPS estimate of $4.06 is a $0.12 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $1.55 Billion. If reported, that would be a 9.93% increase over the year-ago quarter. Recently, Nomura Initiated STJ at Buy (Mar 17, 2016). Previously, Canaccord Genuity upgraded STJ from Sell to Hold. The average price target for STJ shares is $66.81, which is 7.85% above where the stock opened this morning. See more in (NYSE:STJ) Similar Articles: Company Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical CardioMEMS HF System Prompts Changes That Improve Heart Failure Management and Reduce Hospitalizations Stock Update: St. Jude Medical Inc (NYSE:STJ) – St. Jude Medical Announces Launch of OPTIS Mobile System in Europe and Japan